Clinical Trial Detail

NCT ID NCT02372006
Title Trial of Afatinib in Pediatric Tumours
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Boehringer Ingelheim
Indications

malignant peripheral nerve sheath tumor

pediatric ependymoma

medulloblastoma

astrocytoma

brain glioma

neuroblastoma

malignant glioma

rhabdomyosarcoma

Therapies

Afatinib

Age Groups: child

Additional content available in CKB BOOST